Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 1, 2011, Pages 85-90

  Villegas, Enrique ^a   Santiago, Olivia ^a   Carrillo, Jose Antonio ^a   Sorlózano, Antonio ^a   Guerrero, Miguel ^b   Fernández, Oscar ^b   Gutiérrez, José ^a,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Cerebrospinal fluid; DNA; Epstein Barr virus; Intrathecal synthesis; Multiple sclerosis

Indexed keywords

EPSTEIN BARR VIRUS ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN 1; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CASE CONTROL STUDY; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DNA DETERMINATION; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; DNA, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 79955042834     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.11.013     Document Type: Article

References (33)

1. Alotaibi S., Kennnedy J., Tellier R., Stephens D., Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. JAMA 2004, 291:1875-1879.
2. Alvarez-Lafuente R., de las Heras V., Bartolome M., Garcia-Montojo M., Arroyo R. Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol 2006, 16:20-27.
3. Alvarez-Lafuente R., García-Montojo M., De Las Heras V., Domínguez-Mozo M.I., Bartolome M., Benito-Martin M.S., Arroyo R. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler 2008, 14:595-601.
4. Ascherio A., Munger K.L., Lennette E.T., Spiegelman D., Hernán M.A., Olek M.J., Hankinson S.E., Hunter D.J. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001, 286:3083-3088.
5. Bray P.F., Luka J., Bray P.F., Culp K.W., Schlight J.P. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992, 42:1798-1804.
6. Buljevac D., van Doornum G.J.J., Flach H.Z., Groen J., Osterhaus A.D., Hop W., van Doorn P.A., van der Meché F.G., Hintzen R.Q. Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 2005, 76:1377-1381.
7. Castellazzi M., Tamborino C., Cani A., Negri E., Baldi E., Seraceni S., Tola M.R., Granieri E., Contini C., Fainardi E. Epstein-Barr virus-specific antibody response in cerobrospinal fluid and serum of patients with multiple sclerosis. Mult Scler 2010, 16:883-887.
8. Cepok S., Zhou D., Srivastava R., Nessler S., Stei S., Büssow K., Sommer N., Hemmer B. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 2005, 115:1352-1360.
9. Denne C., Kleines M., Dieckhöfer A., Ritter K., Scheithauer S., Merz U., Häusler M. Intrathecal synthesis of anti-viral antibodies in pediatric patients. Eur J Paediatr Neurol 2007, 11:29-34.
10. Franciotta D., Bestetti A., Sala S., Perucca P., Jarius S., Price R.W., Di Stefano A.L., Cinque P. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum. Acta Neurol Belg 2009, 109:277-282.
11. Hobart J., Freeman J., Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000, 123:1027-1040.
12. Jacobi C., Lange P., Reiber H. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response. J Neuroimmunol 2007, 187:139-146.
13. Jafari N., van Nierop G.P., Verjans G.M., Osterhaus A.D., Middeldorp J.M., Hintzen R.Q. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis. J Clin Virol 2010, 49:26-31.
14. Jaquiéry E., Jilek S., Schulep M., Meylan P., Lysandropoulos A., Panteleo G., Du Pasquier R.A. Intrathecal immune responses to EBV in early MS. Eur J Immunol 2010, 40:878-887.
15. Lindsey J.W., Hatfield L.M., Crawford M.P., Patel S. Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis. Mult Scler 2009, 15:153-158.
16. Lünemann J.D., Edwards N., Muraro P.A., Hayashi S., Cohen J.I., Münz C., Martin R. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006, 129:1493-1506.
17. Mancuso R., Delbue S., Borghi E., Pagani E., Calvo M.G., Caputo D., Granieri E., Ferrante P. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 2007, 79:192-199.
18. Meerbach A., Gruhn B., Egerer R., Reischl U., Zintl F., Wutzler P. Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases. J Med Virol 2001, 65:348-357.
19. Myhr K.M., Riise T., Barrett-Connor E., Myrmel H., Vedeler C., Gronning M., Kalvenes M.B., Nyland H. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 1998, 64:539-542.
20. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N Engl J Med 2000, 343:938-952.
21. Pohl D., Krone B., Rostasy K., Kahler E., Brunner E., Lehnert M., Wagner H.J., Gartner J., Hanefeld F. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006, 67:2063-2065.
22. Pohl D., Rostasy K., Jacobi C., Lange P., Nau R., Krone B., Hanefeld F. Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis. J Neurol 2010, 257:212-216.
23. Reiber H., Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in the brain. Clin Chem 1991, 37:1153-1160.
24. Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease related data patterns and evaluation programs. J Neurol Sci 2001, 184:101-122.
25. Robinson-Agramonte M., Reiber H., Cabrera-Gomez J.A., Galvizu R. Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients. Acta Neurol Scand 2007, 115:312-318.
26. Salvetti M., Giovannoni G., Aloisi F. Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol 2009, 22:201-206.
27. Santiago O., Gutierrez J., Sorlozano A., de Dios Luna J., Villegas E., Fernandez O. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis 2010, 29:857-866.
28. Sargsyan S.A., Shearer A.J., Ritchie A.M., Burgoon M.P., Anderson S., Hemmer B., Stadelmann C., Gattenlóhner S., Owens G.P., Gilden D., Bennett J.L. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010, 74:1127-1135.
29. Sotelo J., Ordonez G., Pineda B. Varicella-zoster virus at relapses of multiple sclerosis. J Neurol 2007, 254:493-500.
30. Sumaya C.V., Myers L.W., Ellison G.W., Ench Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 1985, 17:371-377.
31. Wagner H.J., Munger K.L., Ascherio A. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis. Eur J Neurol 2004, 11:833-834.
32. Wandinger K.P., Jabs W., Siekhaus A., Bubel S., Trillenberg P., Wagner H.J., Wessel K., Kirchner H., Hennig H. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 2000, 55:178-184.
33. Yamamoto M., Kimura H., Hironaka T., Hirai K., Hasegawa S., Kuzushima K., Shibata M., Morishima T. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol 1995, 33:1765-1768.